Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1673310 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Nuclear Factor (erythroid-Derived 2)-Like 2 (NFE2L2) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminal of human NFE2L2, identical to the related mouse and rat sequences.Immunogen affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Targeted disruption of Nrf2 causes regenerative immune-mediated hemolytic anemia.
Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation.
Chromosomal localization of the human NF-E2 family of bZIP transcription factors by fluorescence in situ hybridization.
Lee JM, Chan K, Kan YW, Johnson JA
Proceedings of the National Academy of Sciences of the United States of America 2004 Jun 29;101(26):9751-6
Proceedings of the National Academy of Sciences of the United States of America 2004 Jun 29;101(26):9751-6
Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation.
He CH, Gong P, Hu B, Stewart D, Choi ME, Choi AM, Alam J
The Journal of biological chemistry 2001 Jun 15;276(24):20858-65
The Journal of biological chemistry 2001 Jun 15;276(24):20858-65
Chromosomal localization of the human NF-E2 family of bZIP transcription factors by fluorescence in situ hybridization.
Chan JY, Cheung MC, Moi P, Chan K, Kan YW
Human genetics 1995 Mar;95(3):265-9
Human genetics 1995 Mar;95(3):265-9
No comments: Submit comment
No validations: Submit validation data